For: | Cao WT, Huang R, Liu S, Fan YH, Xu MS, Xu Y, Ni H. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy. World J Gastroenterol 2022; 28(23): 2582-2596 [PMID: 35949356 DOI: 10.3748/wjg.v28.i23.2582] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i23/2582.htm |
Number | Citing Articles |
1 |
Junya Song, Huihui Zhang, Huihua Zhang, Ximing Xu, Xiaohua Liang, Yongfang Liu, Xiaomei Song, Hong Guo, Xue Zhan, Jinlin Song, Xiaoqin Zhou. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study. Pediatric Discovery 2024; doi: 10.1002/pdi3.96
|